Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)

SHA:688513 Revenue

Chengdu Easton Biopharmaceuticals had revenue of 364.69M CNY in the quarter ending September 30, 2025, a decrease of -1.55%. This brings the company's revenue in the last twelve months to 1.33B, up 1.66% year-over-year. In the year 2024, Chengdu Easton Biopharmaceuticals had annual revenue of 1.35B with 20.82% growth.

• Revenue (ttm): 1.33B
• Revenue Growth: +1.66%
• P/S Ratio: 7.58
• Revenue / Employee: 873.16K
• Employees: 1,522
• Market Cap: 10.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.35B	232.63M	20.82%
Dec 31, 2023	1.12B	-53.39M	-4.56%
Dec 31, 2022	1.17B	147.58M	14.43%
Dec 31, 2021	1.02B	101.02M	10.96%
Dec 31, 2020	921.92M	-25.32M	-2.67%